RT Journal Article
SR Electronic
T1 Review: azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn’s disease
JF Evidence Based Medicine
JO Evid Based Med
FD BMJ Publishing Group Ltd
SP 115
OP 115
DO 10.1136/ebm.13.4.115
VO 13
IS 4
YR 2008
UL http://ebm.bmj.com/content/13/4/115.abstract
AB